Navigation Links
Local Research Foundation Achieves Milestone in Fight Against Cancer
Date:10/23/2008

CHRISTUS Stehlin Foundation for Cancer Research Develops Innovative

Anticancer Drug

HOUSTON, Oct. 23 /PRNewswire/ -- Almost everyone knows the devastation that cancer brings to families, workplaces and communities, and many Houstonians are aware of well-known local cancer treatment institutions. Few, however, may be familiar with the CHRISTUS Stehlin Foundation for Cancer Research, a nationally recognized leader in cancer research located in Houston, which recently achieved a milestone in their battle against cancer.

The CHRISTUS Stehlin Foundation recently received word from the Food and Drug Administration that CZ48, a promising anticancer drug they discovered and developed, was approved to begin Phase I (human) clinical trials. This is a large step in the journey to offer this potentially lifesaving drug to people suffering from cancer.

This is a remarkable accomplishment, since past records show that for every 5,000 to 10,000 oncology compounds discovered, only 250 make it to pre-clinical phases, and only five (one-tenth of one percent) are approved by the FDA for these human studies.

CZ48 is a derivative of extracts from a Chinese tree, the Camptotheca Acuminata, which more than 45 years ago showed potent anticancer activity against a type of mouse leukemia. The Stehlin Foundation has been researching cancer treatment with the Camptothecin family of compounds since 1988, and as a pioneer in the development of the Camptothecin family of drugs, has synthesized and tested more than 200 Camptothecin derivatives. In fact, the New York Academy of Science wrote, "Camptothecins can be envisioned as the ultimate anticancer drugs when fully developed."

The first phase of the trial has begun at the University of New Mexico Cancer Center in Albuquerque, N.M., and plans are also under way to offer the trial at Vanderbilt-Ingram Cancer Center in Nashville, Tenn. This phase of the clinical trial process
'/>"/>

SOURCE CHRISTUS Stehlin Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants
2. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
3. Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent
4. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
5. Banner Alzheimers Institute and Sun Health Research Institute Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
6. New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases
7. On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Established and new medical technology service ... penetrate the growing Eastern European medical devices market. ... team and regional/local offices, reducing the costs incurred ... crucial advantage as medical technology service providers are ... New analysis from Frost & Sullivan, Medical Technologies ...
(Date:9/30/2014)... , Sept. 30, 2014 CytRx ... research and development company specializing in oncology, today ... clinical trial evaluating aldoxorubicin compared to topotecan in ... who have relapsed or were refractory to prior ... widely-used chemotherapeutic agent, doxorubicin. CytRx has received Orphan ...
(Date:9/29/2014)...  Repeated exposure to broad-spectrum antibiotics in the first ... obesity, say researchers from The Children,s Hospital of ... on data from electronic health records from the extensive ... that children with four or more exposures to broad ... be at risk for obesity. The study, published online ...
Breaking Medicine Technology:Global Medical Manufacturers Turn to Distributors to Tap the Eastern European Market 2Global Medical Manufacturers Turn to Distributors to Tap the Eastern European Market 3CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 2CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 3CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 4CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 5Antibiotic Use by Age 2 Associated with Obesity Risk 2Antibiotic Use by Age 2 Associated with Obesity Risk 3
(Date:9/30/2014)... (PRWEB) September 30, 2014 The ... reach USD 8,020.1 million by 2020, according to ... Growing demand for personalized medicine and theranostics, and ... are expected to be key factors driving market ... growing global base of geriatric population and chronic ...
(Date:9/30/2014)... During this online virtual event, ... health including achieving hormonal balance, relieving menopause symptoms, ... , The details of the ... 6-9, 2014, Location: Online Event, Registration: Complimentary , ... , Monday, October 6th, Steven F. Hotze, M.D., ...
(Date:9/30/2014)... Oxnard, CA (PRWEB) September 30, 2014 ... the Anacapa Dental Art Institute in Oxnard and Thousand ... Bangalore today and tomorrow to provide training on full ... previous dental work, placing implants, providing cosmetic dentistry, correcting ... Dr. Jivraj said. , Dr. Jivraj, who has traveled ...
(Date:9/30/2014)... Washington, DC (PRWEB) September ... **MEDIA ADVISORY** , ... Contact:    Anne Barnwell, 910.554.1505, abarnwell(at)hopeforthewarriors(dot)org ... Give Hope® Celebration , ... , Address:    The Army and ...
(Date:9/30/2014)... York (PRWEB) September 30, 2014 ... of Hudson Allergy , will discuss how restaurants ... allergies and other special dietary restrictions at the ... & Food Service Professionals, October 21 in New York ... this incredibly important topic to such an engaged industry ...
Breaking Medicine News(10 mins):Health News:Global Molecular Diagnostics Market Is Expected To Be Worth $8,020.1 million by 2020: Grand View Research, Inc. 2Health News:Global Molecular Diagnostics Market Is Expected To Be Worth $8,020.1 million by 2020: Grand View Research, Inc. 3Health News:Global Molecular Diagnostics Market Is Expected To Be Worth $8,020.1 million by 2020: Grand View Research, Inc. 4Health News:Global Molecular Diagnostics Market Is Expected To Be Worth $8,020.1 million by 2020: Grand View Research, Inc. 5Health News:Global Molecular Diagnostics Market Is Expected To Be Worth $8,020.1 million by 2020: Grand View Research, Inc. 6Health News:Hotze Health & Wellness Center Announces First Natural Health Summit 2Health News:World-Renowned Dental Implant Expert, International Instructor in India Speaking about Reconstructive Dentistry 2Health News:World-Renowned Dental Implant Expert, International Instructor in India Speaking about Reconstructive Dentistry 3Health News:World-Renowned Dental Implant Expert, International Instructor in India Speaking about Reconstructive Dentistry 4Health News:World-Renowned Dental Implant Expert, International Instructor in India Speaking about Reconstructive Dentistry 5Health News:Hope For The Warriors' Got Heart, Give Hope Celebration Media Advisory 2Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 2Health News:Hudson Allergy’s Dr. Julie Kuriakose to Speak at Prestigious Food Allergy Conference in New York City 3
... how we put the brakes on a racing heartbeat. ... Chicago explain in the May 11 issue of Circulation Research ... the rapid beating of the heart's "fight-or-flight" reaction to adrenaline. ... is responsible for setting the pace of the beating heart, ...
... The central government is aiming for 100 percent registration of ... Death Act 1969 that would simplify the process, an ... serious issue as this helps in maintaining a record for ... the birth registration record is 64 percent as some of ...
... 100 percent registration of births by 2010 by amending the ... simplify the process, an official said Friday. ,'Registration ... maintaining a record for a person for his or her ... percent as some of the states have still not implemented ...
... a single sphere in the US they would like to ... is the cooked chickens market. ,The U.S. ... to familiarize the U.S. market with its cooked chickens." ... about such common practices among Chinese farmers, like flooding crops ...
... of motor disorders: stiffness, slowness, tremors, difficulties walking and ... other symptoms with narcolepsy, a sleep disorder characterized by ... and general sleep disorder. ,Now a team ... why the two disorders share something in common: ...
... receiver Robert Sillen, hired to improve healthcare for state ... his jurisdiction. ,According to Sillen the 50-page ... and protect California communities from diseases carried by inmates ... says, taxpayers will get more for their dollar from ...
Cached Medicine News:Health News:Slowing the Racing Heart 2Health News:Government to Amend Birth Registration Act 2Health News:Government to Amend Birth Registration Act 2Health News:China Eyeing US Cooked Chickens Market 2Health News:UCLA Researchers Discover Link Between Parkinsons and Narcolepsy 2Health News:Brickbats And Bouquets For U.S Prison Healthcare In-Charge 2Health News:Brickbats And Bouquets For U.S Prison Healthcare In-Charge 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: